Advertisement
Screener

Agile Therapeutics, Inc. Advertising Expense

Agile Therapeutics, Inc. Advertising Expense

Agile Therapeutics, Inc. reported Advertising Expense of $0 for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-12.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AdvertisingExpense · last filed 2024-08-12

  • Agile Therapeutics, Inc. advertising expense for the quarter ending 2024-06-30 was $0.00.
  • Agile Therapeutics, Inc. advertising expense for the quarter ending 2024-03-31 was $0.00.
  • Agile Therapeutics, Inc. advertising expense for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
  • Agile Therapeutics, Inc. advertising expense for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
  • Agile Therapeutics, Inc. advertising expense for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • Agile Therapeutics, Inc. advertising expense for fiscal 2022 was $8.20M, a 40.58% decline from fiscal 2021.
  • Agile Therapeutics, Inc. advertising expense for fiscal 2021 was $13.80M, a 150.91% increase from fiscal 2020.
  • Agile Therapeutics, Inc. advertising expense for fiscal 2020 was $5.50M.
Period endAdvertising Expense 3 monthAdvertising Expense 6 monthAdvertising Expense 9 monthAdvertising Expense 12 month
2024-06-30$0.00
10-Q · filed 2024-08-12
$0.00
10-Q · filed 2024-08-12
$0.00
derived: sum of 3 quarters · filed 2024-08-12
$0.00
derived: sum of 4 quarters · filed 2024-08-12
2024-03-31$0.00
10-Q · filed 2024-05-15
$0.00
derived: sum of 2 quarters · filed 2024-05-15
$0.00
derived: sum of 3 quarters · filed 2024-05-15
$0.00
derived: sum of 4 quarters · filed 2024-08-12
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$0.00
derived: sum of 2 quarters · filed 2024-03-28
$0.00
derived: sum of 3 quarters · filed 2024-08-12
$0.00
10-K · filed 2024-03-28
2023-09-30$0.00
10-Q · filed 2023-11-09
$0.00
derived: sum of 2 quarters · filed 2024-08-12
$0.00
10-Q · filed 2023-11-09
$2.10M
derived: sum of 4 quarters · filed 2024-08-12
2023-06-30$0.00
10-Q · filed 2024-08-12
$0.00
10-Q · filed 2024-08-12
$2.10M
derived: sum of 3 quarters · filed 2024-08-12
$3.00M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31$0.00
10-Q · filed 2024-05-15
$2.10M
derived: sum of 2 quarters · filed 2024-05-15
$3.00M
derived: sum of 3 quarters · filed 2024-05-15
$4.90M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$3.00M
derived: sum of 2 quarters · filed 2024-03-28
$4.90M
derived: sum of 3 quarters · filed 2024-03-28
$8.20M
10-K · filed 2024-03-28
2022-09-30$900.00K
10-Q · filed 2023-11-09
$2.80M
derived: sum of 2 quarters · filed 2023-11-09
$6.10M
10-Q · filed 2023-11-09
$11.10M
derived: sum of 4 quarters · filed 2024-03-28
2022-06-30$1.90M
10-Q · filed 2023-08-09
$5.20M
10-Q · filed 2023-08-09
$10.20M
derived: sum of 3 quarters · filed 2024-03-28
$12.90M
derived: sum of 4 quarters · filed 2024-03-28
2022-03-31$3.30M
10-Q · filed 2023-05-11
$8.30M
derived: sum of 2 quarters · filed 2024-03-28
$11.00M
derived: sum of 3 quarters · filed 2024-03-28
$14.00M
derived: sum of 4 quarters · filed 2024-03-28
2021-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$7.70M
derived: sum of 2 quarters · filed 2024-03-28
$10.70M
derived: sum of 3 quarters · filed 2024-03-28
$13.80M
10-K · filed 2024-03-28
2021-09-30$2.70M
10-Q · filed 2022-11-07
$5.70M
derived: sum of 2 quarters · filed 2022-11-07
$8.80M
10-Q · filed 2022-11-07
$14.30M
derived: sum of 4 quarters · filed 2023-03-23
2021-06-30$3.00M
10-Q · filed 2022-08-11
$6.10M
10-Q · filed 2022-08-11
$11.60M
derived: sum of 3 quarters · filed 2023-03-23
$11.60M
derived: sum of 4 quarters · filed 2023-03-23
2021-03-31$3.10M
10-Q · filed 2022-05-12
$8.60M
derived: sum of 2 quarters · filed 2023-03-23
$8.60M
derived: sum of 3 quarters · filed 2023-03-23
$8.60M
derived: sum of 4 quarters · filed 2023-03-23
2020-12-31$5.50M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-23
$5.50M
derived: sum of 2 quarters · filed 2023-03-23
$5.50M
derived: sum of 3 quarters · filed 2023-03-23
$5.50M
10-K · filed 2023-03-23
2020-09-30$0.00
10-Q/A · filed 2021-12-30
$0.00
derived: sum of 2 quarters · filed 2021-12-30
$0.00
10-Q/A · filed 2021-12-30
2020-06-30$0.00
10-Q · filed 2021-07-26
$0.00
10-Q · filed 2021-07-26
2020-03-31$0.00
10-Q · filed 2021-05-04
2019-12-31$0.00
10-K · filed 2021-03-01